ENTITY
Biogen Inc

Biogen Inc (BIIB US)

144
Analysis
Health CareUnited States
Biogen Inc. develops, manufactures, and commercializes therapies, focusing on neurology, oncology, and immunology. The Company's products address diseases such as multiple sclerosis, non-Hodgkin's lymphoma, rheumatoid arthritis, Crohn's disease, and psoriasis.
more
08 Dec 2015 11:42

Investing in the Internet of Things (IoT)

In today's digitized world, everything is connected and  'smart' - our phones are packed with ever more functionality, we can surf the net directly...

Logo
1.3k Views
Share
12 Nov 2015 09:34

Healthcare Observer: As Long-Term Patent Exposure Ebbs, Innovation in Big Pharma Pipelines Support

Pipeline innovation outpacing patent losses represents a core element of the wide moat ratings for most of the Big Pharma firms. Slowing patent...

Logo
327 Views
Share
11 Oct 2015 23:13

HILLARY! Scourge of Wall, Savior of Main - Preventer of Market Crashes, and Economic Crises

On October 8th, Hillary Clinton offered an Op-Ed on Bloomberg Views (available on the website here) which was a shorter version of...

Logo
297 Views
Share
07 Oct 2015 11:15

Morningstar Healthcare Observer: Biotech Industry Undervalued

The median price/fair value in our biotech universe is 0.87, and in late September valuations fell to their cheapest levels since 2011. While this...

Logo
291 Views
Share
06 Oct 2015 11:03

SoulCycle IPO - Good for your portfolio and your soul?

"Dance party on a bike" - that's how the founders of SoulCycle like to describe their business. SoulCycle is a lifestyle and fitness brand that...

Logo
255 Views
Share
x